ORGANICELL REGENERATIVE MEDICINE, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

Item 7.01 Regulation FD Disclosure.

On January 12, 2021, Organicell issued a press release announcing that will host a live online discussion on the topic of COVID-19 long-haulers on Wednesday, January 13th at 7 P.M. EST.

To tune into the event live visit :

https://us02web.zoom.us/webinar/register/WN_Vqi_TnlOTFS1Lom1NElpnQ

Following the live presentation, replays of the event will be available on the Company's website at www.organicell.com.

A copy of the press release is included as Exhibit 99.1 to this report.

In accordance with General Instruction B.2 of Form 8-K, the information furnished pursuant to this Item 7.01, and including Exhibit 99.1 furnished herewith, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits



Exhibit No. Description

99.1 Press Release dated January 12, 2021

© Edgar Online, source Glimpses